Danqi Piantang Jiaonang (DJ), a traditional Chinese medicine, in poststroke recovery

Stroke

Volumn 40, Issue 3, 2009, Pages 859-863

  Chen, Christopher ^a,h   Venketasubramanian, N ^b   Gan, Robert N ^b   Lambert, Caroline ^c   Picard, David ^c   Chan, Bernard P L ^d   Chan, Edwin ^e   Bousser, Marie G ^f   Xuemin, Shi ^g  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^c Moleac Pte Ltd   (Singapore)

^d NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^e Clinical Trials and Epidemiology Research Unit   (Singapore)

^f HÔPITAL LARIBOISIÈRE   (France)

^g TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^h NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Cerebral infarct; Randomized controlled trials; Stroke recovery; Traditional Chinese medicine

Indexed keywords

BUCHANG NAOXINTONG JIAONANG; CHINESE DRUG; DANQI PIANTANG JIAONANG; DEXTRIN; HERBACEOUS AGENT; NEUROAID; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASTRAGALUS PLANT; BLOOD CELL COUNT; CEREBROVASCULAR ACCIDENT; CHINESE MEDICINE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC THERAPEUTIC EFFECTS OF APOPLEXY SCALE; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; KIDNEY FUNCTION; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; PLANT ROOT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SALVIA MILTIORRHIZA; SCORING SYSTEM; SIDE EFFECT; TREATMENT OUTCOME; COMPARATIVE STUDY; CONVALESCENCE; MIDDLE AGED; MOTOR PERFORMANCE; PATHOPHYSIOLOGY; STROKE;

ADULT; AGED; DOUBLE-BLIND METHOD; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; MOTOR SKILLS; RECOVERY OF FUNCTION; STROKE; TREATMENT OUTCOME;

EID: 62449097163     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.531616     Document Type: Article

References (11)

1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442.
2. Wolfe CD. The impact of stroke. Br Med Bull. 2000;56:275-286.
3. Wu B, Liu M, Liu H, Li W, Tan S, Zhang S, Fang Y. Meta-analysis of traditional Chinese patent medicine for ischemic stroke. Stroke. 2007;38: 1973-1979.
4. Rausch WD, Liu S, Gille G, Radad K. Neuroprotective effects of ginsenosides. Acta Neurobiol Exp (Wars). 2006;66:369-375.
5. Bei W, Peng W, Zang L, Xie Z, Hu D, Xu A. Neuroprotective effects of a standardized extract of Diospyros kaki leaves on MCAO transient focal cerebral ischemic rats and cultured neurons injured by glutamate or hypoxia. Planta Med. 2007;73:636-643.
6. Tang Q. Clinical study report on efficiency of Danqi Piantan Capsule in the treatment of apoplexy due to deficiency of qi and stasis of Wood syndrome (Dan Qi Pian Tan Jiao Nang Zhi Liao Qi Xu Xue Yu Xing Zhong Feng De Er Qi Lin Chuang Yan Jiu Bao Gao). Zhong Guo Zhong Yi Yao Ke Ji. 2003;10:69.
7. List of the most promising Chinese innovations 2006. The Ministry of Science and Technology of the People's Republic of China. Available at: www.most.gov.cn/tztg/200610/P020061031645631695813.xls. 2006. Accessed January 2009.
8. Encephalopathy Emergency Scientific Research Coordination Team of the State Traditional Chinese Medicine Authority. The standards for evaluating the diagnostic Therapeutic Effects of Apoplexy (DTER). Zhonghua Shen Jing Ke ZaZhI. 1996;29:379.
9. Clinical Principle on Treating Apoplexy With New Traditional Chinese Medicine. Principle of Clinical Research for New Traditional Herbs. Bureau of Drug Administration & Policy, Ministry of Public Health, People's Republic of China; 1993:32-36.
10. Review Manager (RevMan) [computer program]. Version 4.2 for Windows. Copenhagen: The Nordic Cocnrane Centre, The Cochrane Collaboration; 2003.
11. WHO Traditional Medicine Strategy 2002-2005. Available at: http://whqlibdoc.who.int/hq/2002/WHO_EDM_TRM_2002.1.pdf. 2002. Accessed January 2009.